Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections
Brady T. Hickerson(United States Food and Drug Administration), Brian B. Gowen(Utah State University)
Cited by 13
Related Papers
Comparison of the Antiviral Activity of Remdesivir, Chloroquine, and Interferon-β as Single or Dual Agents Against the Human Beta-Coronavirus OC43
|Journal of Interferon & Cytokine Research|2023|5